Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

OPTIMIZING PRE-EXPOSURE PROPHYLAXIS WITH TDF-FTC AND TAF-FTC FOR INSERTIVE SEX

By Jimmy He PharmD, DScMarch 3, 2023

…unknown. The CHAPS trial addressed these gaps of knowledge and pre-clinically assessed post-exposure prophylaxis (PEP) in foreskin. Methods: Phase 2 open-label, randomised controlled trial in Uganda and South Africa. 144…

PHARMACY-BASED PrEP DELIVERY IN KENYA: FINDINGS FROM A PILOT STUDY EXTENSION

By Jimmy He PharmD, DScMarch 24, 2023

…additionally offered post-exposure prophylaxis (PEP) and sexually transmitted infection (STI) testing. Methods: We piloted the modified delivery model in 12 private pharmacies in Kisumu and Kiambu Counties. Pharmacy providers were…

Randomized Trial of SEARCH Dynamic Choice HIV Prevention Including Injectable Cabotegravir (CAB-LA)

By Jimmy He PharmD, DScApril 26, 2024

…(SoC) among men and women at risk for HIV in rural Uganda and Kenya. Methods: Participants were recruited from three randomized studies of the SEARCH dynamic choice HIV prevention (DCP)…

FUNCTION, HOMING, AND RESIDENCY OF T-CELL IMMUNE RESPONSES AGAINST SARS-CoV-2

By Jimmy He PharmD, DScApril 22, 2021

…capabilities of SARS-CoV-2-specific CD4+ and CD8+T cells were measured by FACS after stimulation with a pool of overlapping SARS-CoV-2 viral peptides (M, N and S). Pattern variations associated with viral-specific…

DOXYCYCLINE POSTEXPOSURE PROPHYLAXIS FOR PREVENTION OF STIs AMONG CISGENDER WOMEN

By Jimmy He PharmD, DScMarch 24, 2023

…prophylaxis (PEP) was efficacious at preventing STIs among cisgender men who have sex with men and transgender women, but no trials among cisgender women have been done. Methods: We conducted…

PARTNER TESTING SERVICES TO ACHIEVE HIV EPIDEMIC CONTROL IN 9 PEPFAR COUNTRIES, 2019

By Jimmy He PharmD, DScApril 27, 2020

…strategy.Data is collected on PNS, contacts of index cases and HIV indicators as Monitoring, Evaluation and Reporting (MER) data.These data measures progress towards HIV epidemic control by reaching the first UNAIDS…

Labelled High Affinity TCRs for Detection of HIV Epitopes on Infected Cells: How Low Can We Go?

By Jimmy He PharmD, DScMarch 6, 2024

…analysed for expression of viral peptide-HLA complexes by total internal reflection microscopy (TIRF; single molecule epitope counting). Results: HIV Gag peptide-HLA complexes could be identified on peptide pulsed cells using…

442 – Mpox-Specific T-Cell Responses in Recovered and Vaccinated Individuals

By Jimmy He PharmD, DScMarch 20, 2025

…may be effective in immune clearance. Methods Using the Immune Epitope Database, we created a panel of 46 peptides derived from proteins produced early in poxvirus infection also present in…

Protease Activity in the Lung in HIV-Associated Obstructive Lung Disease (OLD)

By Jimmy He PharmD, DScMarch 6, 2024

Background: Obstructive lung disease (OLD) is increasingly common among persons with HIV (PWH). The role of proteases in HIV associated OLD is unknown. Methods: We performed mass spectrometry (MS) analysis…

FDG PET/CT Imaging of Lymph Nodes As a Measure of the HIV Reservoir in Humans

By Enthusiast Inc MDFebruary 16, 2016

…imaging of the axillary lymph nodes may provide a method to non-invasively measure reservoirs of viral persistence in HIV and assess response to different antiretroviral therapies or anti-inflammatory interventions.    …

←1
23456789101112
…1314151617…
1819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top